A total of 3,462 incentive drugs, which were endorsed by bioequivalence tests, are available for substitute dispensing at the end of January this year, according to the Health Insurance Review Agency.
The Health authorities said the figure decreased by 129 items in June from a year earlier since July 2001, which was chiefly attributed to fabricated test results of widely prescribed generic d...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.